U.K. Pharma Stock News

If you are wondering whether Lloyds Banking Group shares still offer value after their recent run, this article will walk through what the current price might be implying about the stock. The share price recently closed at £1.0245, with returns of 3.2% year to date and 47.4% over the past year, alongside shorter term moves of a 1.6% decline over 7 days and a 2.0% decline over 30 days. These changes can shift how investors think about both upside and risk. Recent news coverage has focused on...

GSK agreed to acquire Canadian biotech 35Pharma for about US$950m. The deal brings HS235, an investigational therapy for pulmonary hypertension and related metabolic issues, into GSK's cardiopulmonary pipeline. The transaction aims to expand GSK's respiratory, immunology, and inflammation portfolio within specialty medicines. LSE:GSK is adding 35Pharma at a time when its share price stands at £22.01, with returns of 20.2% year to date and 56.2% over the past year. Over three and five years,...

Rolls-Royce Holdings announced a multi-year share buyback programme of up to £9b. The company sharply raised its mid term financial targets alongside the buyback plan. Rolls-Royce is seeking substantial UK government support for new narrow body aircraft engines and small modular reactors. For investors watching Rolls-Royce Holdings (LSE:RR.), these moves come after a very large three-year share price gain and a current price of £13.335. The stock is up 11.4% year to date and 81.5% over the...

BAE Systems (LSE:BA) has secured a U.S. Army contract worth more than US$500 million to supply advanced self-propelled howitzers. The company has reached a production milestone with the delivery of its 100,000th APKWS laser guidance kit. BAE Systems has also shown a new modular electromagnetic attack technology with scalable capabilities. For you as an investor, these updates highlight several key product lines at BAE Systems, from artillery platforms to precision munitions and electronic...

Lloyds Banking Group (LSE:LLOY) is back in focus for investors after recent share price moves, with the stock showing different return patterns over the past week, month and past 3 months. See our latest analysis for Lloyds Banking Group. At a share price of £1.049, Lloyds Banking Group has seen short term share price momentum cool compared to its recent 90 day share price return of 9.11%. At the same time, the 1 year total shareholder return of 53.60% and 3 year total shareholder return of...

Shell and METLEN have signed an LNG supply and trading agreement tied to the Vertical Gas Corridor, aimed at improving regional gas flows in Europe. Shell has begun arbitration proceedings with Kazakhstan related to environmental fines at the Kashagan oilfield. These moves come as investors watch how Shell balances European gas growth with legal and environmental disputes. LSE:SHEL is trading at £30.24, with the share price up 12.1% over the past month and 9.6% year to date. Over the past...

If you are wondering whether BP's current share price really reflects its underlying value, you are not alone. This article will walk through what the numbers actually say. Over the short term, BP's share price shows a 1% decline over the last 7 days, a 4.9% return over 30 days, 8.3% year to date, 14.7% over 1 year and 94.3% over 5 years. This performance may lead investors to reassess both its growth potential and its risk profile. Recent headlines around BP have focused on its role as a...

Diageo’s new CEO, Sir Dave Lewis, has halved the dividend, marking a rare cut for LSE:DGE. The company is shifting its focus from a purely premium brand approach toward the mass market. Diageo has abruptly closed its Crown Royal whisky plant in Ontario, affecting more than 200 workers and sparking local backlash. For investors watching LSE:DGE, these decisions come on top of already weak share performance. The share price sits at £15.86, with the stock down 11% over the past week and 23.6%...

FDA approval granted for a new CALQUENCE combination therapy in chronic lymphocytic leukemia. Positive Phase III results reported for BREZTRI in patients with uncontrolled asthma. EMA validates a filing for ENHERTU in HER2 positive breast cancer. AstraZeneca, LSE:AZN, is adding fresh clinical and regulatory progress to a share price that stands at £151.1. The stock has returned 11.2% year to date and 27.9% over the past year, with a 47.7% return over three years and 144.9% over five years...

Context for GSK after recent share moves GSK (LSE:GSK) has recently drawn attention after a mix of short term share price weakness and stronger longer term returns, prompting investors to reassess how its current valuation lines up with recent business performance. See our latest analysis for GSK. The recent 2.1% one day and 2.7% 7 day share price declines contrast with GSK's 16.4% 1 month and 18.3% year to date share price returns, alongside a 54.4% 1 year total shareholder return. This...

Why Fresnillo (LSE:FRES) is on investors’ radar today Fresnillo (LSE:FRES) has attracted attention after a mixed pattern in recent share returns, including a roughly 5% decline over the past day alongside a gain of about 56% in the past 3 months. See our latest analysis for Fresnillo. At a share price of £41.04, Fresnillo’s recent 6% 7 day share price return sits alongside a roughly 56% 90 day share price return and a very large 1 year total shareholder return. Taken together, these figures...

If you are wondering whether HSBC Holdings is attractively priced after its strong run, this article will walk you through what the current share price might mean for long term investors. HSBC's share price closed at £13.98 recently, with returns of 9.1% over 7 days, 9.5% over 30 days, 17.3% year to date and 61.6% over 1 year, so it is understandable if you are questioning what is already priced in. Recent headlines have focused on HSBC's position as a major global bank and ongoing...

Intro Rolls-Royce Holdings (LSE:RR.) stock has been relatively steady over the past week, giving investors a moment to reassess its recent returns and current valuation after a strong 3-month period. See our latest analysis for Rolls-Royce Holdings. While the share price has paused around £13.10 after a strong 23.8% 3 month share price return, the very large 3 year and 5 year total shareholder returns suggest investors have already priced in a substantial shift in expectations and risk...

Lloyds Banking Group (LSE:LLOY) reports new research on UK first-time buyers. Manchester is identified as the leading location outside London for mortgaged first-time home purchases. The findings point to changing patterns in where younger buyers are choosing to purchase homes. Lloyds Banking Group, a major UK retail and commercial bank, is closely tied to trends in mortgages and housing demand. Its latest research on first-time buyers gives investors another datapoint on how younger...

Rio Tinto Group (LSE:RIO) reported record copper and bauxite production in its latest full year update. The group announced an increased dividend alongside revised mineral resources and ore reserves. Rio Tinto confirmed completion of the Arcadium acquisition as part of its growth plans. Operations at the SimFer site in Guinea were suspended following a fatal incident. Rio Tinto Group, trading at £74.61, has seen its share price rise 24.6% year to date and 62.2% over the past year. Over 5...

Glencore has acquired the remainder of veteran trader Rami Weisfisch's cobalt stockpile. The deal is linked to efforts to supply critical metals to U.S. government programs such as Project Vault. The transaction comes as Western buyers look to reduce reliance on China influenced supply chains for key battery materials. LSE:GLEN is closely tied to global battery metals markets, so this cobalt purchase puts the company directly in the flow of U.S. government sourcing plans. The move comes...

Unilever and Google Cloud have agreed a five year partnership focused on accelerating Unilever's digital transformation. The collaboration aims to build an AI first digital backbone to support business operations and marketing across Unilever's global portfolio. The agreement is intended to expand Unilever's use of advanced AI for demand generation, data driven marketing and modern agentic workflows. For investors following Unilever, LSE:ULVR, this partnership comes at a time when the...

HSBC Holdings accelerated its cost cutting program, hitting its target six months early. The bank reduced its managing director ranks while increasing bonuses for top performers. These changes form part of an ongoing overhaul under CEO Georges Elhedery, with a continued pivot to Asia. For investors watching LSE:HSBA, the latest moves come after a period of strong share price performance. The stock is priced at £12.914, with a 1 week return of 1.7%, a 30 day return of 4.9%, and a year to...

If you are wondering whether Diageo shares are offering good value right now, it helps to step back from the headlines and look closely at what the current price actually reflects. The stock last closed at £18.74, with returns of 4.3% over 7 days, 11.9% over 30 days, 16.6% year to date, but a 10.1% decline over 1 year and a 41.6% decline over 3 years, with a 25.7% decline over 5 years shaping how investors may be thinking about risk and potential reward. Recent coverage of Diageo has focused...

Barclays share performance snapshot and recent context With no single headline event driving the latest move, Barclays (LSE:BARC) has drawn attention after a 0.7% one day share decline and a 2.9% fall over the past week. Those shorter term moves sit alongside a 4.2% decline over the past month, an 8.7% gain over the past three months and a 60.9% total return over the past year, putting recent price action into sharper context for investors. See our latest analysis for Barclays. For Barclays,...

Why AstraZeneca is on investors’ radar today AstraZeneca (LSE:AZN) has drawn fresh attention after recent share price moves, with the stock up around 13% over the past month and about 8% over the past 3 months. See our latest analysis for AstraZeneca. That recent 13% 1 month share price return sits on top of a 1 year total shareholder return of about 31% and a 5 year total shareholder return close to 148%. This suggests momentum has been building over time rather than fading. If AstraZeneca’s...

If you are wondering whether GSK shares still offer value after a strong run, this article walks through how the current price stacks up against different ways of estimating what the business might be worth. GSK's share price last closed at £22.06, with returns of 1.0% over 7 days, 22.5% over 30 days, 20.4% year to date, 58.0% over 1 year and 71.5% over 3 years. This performance has put valuation firmly on many investors' radar. Recent headlines have focused on GSK's position as a large...

Pan African Resources (LSE:PAF) reported record first half profits alongside higher gold production. The company also cut net debt sharply, putting it on track to reach a net cash position. Management highlighted stronger gold prices and solid operational performance as key drivers. Pan African Resources, a gold producer listed in London as LSE:PAF, sits in a sector where output levels, cost control and balance sheet strength can quickly change the investment narrative. With gold remaining...

BAE Systems (LSE:BA.) has drawn investor attention after recent share price moves, including a 1 day decline alongside gains over the past week, month, and past 3 months. This has prompted closer scrutiny of its current valuation. See our latest analysis for BAE Systems. The latest 1 day share price decline sits against a stronger trend, with a 90 day share price return of 31.83% and a 1 year total shareholder return of 66.92%, suggesting recent momentum has been building rather than...